Therapeutic Macrophages Patent Application
Summary
The USPTO has published a patent application (US20260085287A1) filed by Resolution Therapeutics Limited for therapeutic macrophages genetically engineered to overexpress Interleukin-10 (IL-10) or IL-10 in combination with Matrix Metallopeptidase 9 (MMP9). This application relates to potential treatments for inflammatory conditions.
What changed
This document is a publication of a patent application filed by Resolution Therapeutics Limited. The application, identified as US20260085287A1, describes therapeutic macrophages engineered to overexpress IL-10 or a combination of IL-10 and MMP9. The intended use is for treating inflammatory conditions, including those with acute or chronic inflammation and fibrotic elements, such as inflammatory organ damage.
As this is a patent application publication, there are no immediate compliance obligations for regulated entities. However, companies in the pharmaceutical and biotechnology sectors should monitor this application and related patents for potential future intellectual property developments and licensing opportunities. The filing date was September 27, 2023, and the publication date is March 26, 2026.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
THERAPEUTIC MACROPHAGES
Application US20260085287A1 Kind: A1 Mar 26, 2026
Assignee
Resolution Therapeutics Limited
Inventors
Lara CAMPANA, Kayleigh THIRLWELL, Niya EKSANDROVA ALEKSIEVA, Rafael Alejandro ARMESILLA DIAZ, Hollie BARTLEY
Abstract
The present invention relates to a macrophage, genetically engineered to overexpress Interleukin-10 (IL-10) or IL-10 in combination with Matrix Metallopeptidase 9 (MMP9). Such a macrophage may be for use in treatment of an inflammatory condition in a subject such as inflammatory organ damage. The inflammatory condition may be acute or chronic and may involve a fibrotic element.
CPC Classifications
C12N 5/0645 A61K 35/15 A61K 40/17 A61K 40/50 A61P 1/16 C07K 14/5428 C12N 5/10 C12N 5/562 C12N 9/6489 C12N 15/85 C12Y 304/24035 C12N 2501/22 C12N 2501/2304 C12N 2501/2313 C12N 2510/00
Filing Date
2023-09-27
Application No.
19112932
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.